These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11503052)

  • 21. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis.
    Liu CJ; Kao JH; Lai MY; Chen PJ; Chen DS
    J Med Virol; 2004 Apr; 72(4):545-50. PubMed ID: 14981756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the core promoter region of hepatitis B virus in patients with chronic hepatitis B.
    Kurosaki M; Enomoto N; Asahina Y; Sakuma I; Ikeda T; Tozuka S; Izumi N; Marumo F; Sato C
    J Med Virol; 1996 Jun; 49(2):115-23. PubMed ID: 8991934
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Identification of hepatitis B virus genotypes in patients with chronic hepatitis B from different nationalities in ethnic minority areas in Yunnan Province, China].
    Bian ZQ; Hua ZL; Yan WY; Liu MQ; Wu DY; Zheng ZX
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(10):681-6. PubMed ID: 16681927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of core promoter mutations with viral breakthrough in chronic hepatitis B patients on long-term lamivudine therapy.
    Kazim SN; Chauhan R; Das BC; Sarin SK
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1525-32. PubMed ID: 16928212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation of hepatitis B virus (HBV) genotypes and mutations in basal core promoter/precore with clinical features of chronic HBV infection.
    Du H; Li T; Zhang HY; He ZP; Dong QM; Duan XZ; Zhuang H
    Liver Int; 2007 Mar; 27(2):240-6. PubMed ID: 17311620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nucleotide mutations associated with hepatitis B e antigen negativity.
    Sun X; Rokuhara A; Tanaka E; Gad A; Mutou H; Matsumoto A; Yoshizawa K; Kiyosawa K
    J Med Virol; 2005 Jun; 76(2):170-5. PubMed ID: 15834874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of sequence changes of precore and core promoter regions in HBeAg-positive chronic hepatitis B patients with and without HBeAg clearance in lamivudine therapy.
    Chen CH; Lee CM; Lu SN; Changchien CS; Wang JC; Wang JH; Hung CH; Hu TH
    J Hepatol; 2006 Jan; 44(1):76-82. PubMed ID: 16298013
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical reactivation during lamivudine treatment correlates with mutations in the precore/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis.
    Marrone A; Zampino R; Karayannis P; Cirillo G; Cesaro G; Guerrera B; Ricciotti R; del Giudice EM; Utili R; Adinolfi LE; Ruggiero G
    Aliment Pharmacol Ther; 2005 Oct; 22(8):707-14. PubMed ID: 16197491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case-control study for early prediction of hepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter.
    Yamaura T; Tanaka E; Matsumoto A; Rokuhara A; Orii K; Yoshizawa K; Miyakawa Y; Kiyosawa K
    J Med Virol; 2003 Aug; 70(4):545-52. PubMed ID: 12794716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HBe antigen loss during lamivudine therapy is not caused by mutations in precore and core promoter genes in patients with chronic hepatitis B.
    Suzuki F; Tsubota A; Arase Y; Suzuki Y; Akuta N; Hosaka T; Someya T; Kobayashi M; Saitoh S; Ikeda K; Kobayashi M; Matsuda M; Satoh J; Takagi K; Kumada H
    J Med Virol; 2003 Jul; 70(3):355-60. PubMed ID: 12766997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2005 Jun; 25(3):564-70. PubMed ID: 15910494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of genotype and precore/basal core promoter mutations of hepatitis B virus in patients with chronic hepatitis B with acute exacerbation.
    Tsai WL; Lo GH; Hsu PI; Lai KH; Lin CK; Chan HH; Chen WC; Cheng JS; Liu YC; Huang TS; Ger LP; Lin HH
    Scand J Gastroenterol; 2008; 43(2):196-201. PubMed ID: 18224565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy.
    Lin CL; Liao LY; Wang CS; Chen PJ; Lai MY; Chen DS; Kao JH
    Liver Int; 2004 Feb; 24(1):9-15. PubMed ID: 15101995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double point mutation in the core promoter region of hepatitis B virus (HBV) genotype C may be related to liver deterioration in patients with chronic HBV infection.
    Nakashima H; Furusyo N; Kubo N; Kashiwagi K; Etoh Y; Kashiwagi S; Hayashi J
    J Gastroenterol Hepatol; 2004 May; 19(5):541-50. PubMed ID: 15086598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pre-Core mutation of HBV among 26 families with history of chronic HBV infection in Shenyang].
    Li Z; Dou X; Liu P
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):239-41. PubMed ID: 12665929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No significant correlation exists between core promoter mutations, viral replication, and liver damage in chronic hepatitis B infection.
    Chun YK; Kim JY; Woo HJ; Oh SM; Kang I; Ha J; Kim SS
    Hepatology; 2000 Nov; 32(5):1154-62. PubMed ID: 11050069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precore and core promoter mutations at the time of HBeAg seroclearance in Chinese patients with chronic hepatitis B.
    Yuan HJ; Ka-Ho Wong D; Doutreloigne J; Sablon E; Lai CL; Yuen MF
    J Infect; 2007 May; 54(5):497-503. PubMed ID: 16997379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical significance of basal core promoter and precore mutations in chronic hepatitis B.
    Ozgenc O; Ozacar T; Erensoy S; Inan N; Ari A; Kuruuzum Z; Bilgic A
    Hepatogastroenterology; 2007 Dec; 54(80):2319-23. PubMed ID: 18265656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community-based epidemiology of hepatitis B virus infection in West Bengal, India: prevalence of hepatitis B e antigen-negative infection and associated viral variants.
    Chowdhury A; Santra A; Chakravorty R; Banerji A; Pal S; Dhali GK; Datta S; Banerji S; Manna B; Chowdhury SR; Bhattacharya SK; Mazumder DG
    J Gastroenterol Hepatol; 2005 Nov; 20(11):1712-20. PubMed ID: 16246191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of core promoter/precore mutations and viral load in e antigen-negative chronic hepatitis B patients.
    Huang YH; Wu JC; Chang TT; Sheen IJ; Huo TI; Lee PC; Su CW; Lee SD
    J Viral Hepat; 2006 May; 13(5):336-42. PubMed ID: 16637865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.